Heterogeneity of the Type I Interferon Signature in Rheumatoid Arthritis: A Potential Limitation for Its Use As a Clinical Biomarker

INTRODUCTION: An increased expression of interferon (IFN)-responding genes (IRGs), the so-called IFN signature, has been reported in rheumatoid arthritis (RA). However, some controversy exists concerning its clinical relevance. The main aim of this study is to evaluate whether quantitative and quali...

Descripción completa

Detalles Bibliográficos
Autores principales: Rodríguez-Carrio, Javier, Alperi-López, Mercedes, López, Patricia, Ballina-García, Francisco J., Suárez, Ana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2018
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5775969/
https://www.ncbi.nlm.nih.gov/pubmed/29387065
http://dx.doi.org/10.3389/fimmu.2017.02007

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5775969/
https://www.ncbi.nlm.nih.gov/pubmed/29387065
http://dx.doi.org/10.3389/fimmu.2017.02007

Ejemplares similares